Potential Protection Against Chronic Diseases Associated With Obesity Following Discovery Of Melanin Production In Fat Tissue

A two-year study conducted by researchers at George Mason University, INOVA Fairfax Hospital and the National Cancer Institute may open the door to new therapies for combating chronic diseases associated with obesity, a condition that affected more than 33 percent of American adults in 2005-06 according to the Centers for Disease Control and Prevention.

While analyzing samples taken from morbidly obese patients undergoing weight loss surgery, the researchers discovered that substantial quantities of melanin... read more

Submitted by Avera

• 55 Views
• 0 Comments

A new weapon in the fight against obesity and diabetes

A study appearing November 5 in the journal Cell Metabolism demonstrates that a synthetic new chemical entity protects against diet-induced obesity, improves glucose tolerance and insulin sensitivity and enhances exercise endurance by enhancing fat utilization in certain target tissues.

The new chemical entity was developed by Sirtris, a a GSK company, and the research study was led by EPFL professor Johan Auwerx, MD, says EurekAlert! release.

Reducing calorie consumption by about 20% has... read more

Submitted by Avera

• 60 Views
• 0 Comments

Red wine pills to fight obesity, diabetes

While testing the compound, called SRT1720, researchers found that it protected mice from weight-gain and insulin disorders – even when they ate a high-fat diet.

They also found that the drug appears to increase energy levels when exercising.

It targets a protein, which is also affected by resveratrol, a chemical in the skins of red grapes that’s believed to combat ageing and help prevent heart disease and cancer.

Submitted by Avera

• 64 Views
• 0 Comments

Energy dense diet ups diabetes risk

The rate of diabetes has doubled in the past decade, according to a report released Thursday by the Centers for Disease Control and Prevention or CDC.

Energy dense diet has been linked in early studies to obesity which has in turn been associated with increased risk of type 2 diabetes. And the editorials for the CDC report said the increased diabetes prevalence has something to do with obesity, which is also on the rise... read more

Submitted by Avera

• 65 Views
• 0 Comments

Minimally Invasive Laparoscopic Gastric Banding Weight Loss Procedure

Allina Hospitals & Clinics' Unity Hospital will present a live weight loss surgery on http://www.or-live.com/unityhospital/2151 at 3 p.m. on Thursday, Oct. 30. Jeffrey Baker, MD, will perform a laparoscopic adjustable gastric band surgery, commonly known as Lap-Band(R) or Realize Band(TM) surgery, while Frederick Johnson, MD answers viewer questions, and talks about the benefits of adjustable banding procedures.

"This is a great opportunity for individuals contemplating weight loss surgery to learn more about a minimally invasive,... read more

Submitted by Avera

• 63 Views
• 0 Comments

Simple Blood Test Predicts Obesity

According to new research from the Monell Center, the degree of change in blood triglyceride levels following a fatty meal may indicate susceptibility to diet-induced obesity. The findings open doors to new methods of identifying people, including children, who are at risk for becoming obese.

Triglycerides are a form of fat that is transported in the blood and stored in the body's fat tissues. They are found in foods and also are manufactured by... read more

Submitted by Avera

• 74 Views
• 0 Comments

Diabetes Risk Higher Among Children In Low-Income Families

A study of 1,402 fourth grade students ages 8-10 years old in Texas aimed to determine the prevalence of high blood glucose, obesity, low fitness and energy insufficiency levels among children from poor families. Nearly 75 percent of the participants lived in households with less than $20,400 annual income. The racial/ethnic backgrounds of the students were 80 percent Mexican-American, 10 percent African-American, 5 percent Asian-American and 5 percent non-Hispanic white.

Submitted by Avera

• 44 Views
• 0 Comments

Generex to Host Satellite Symposium At World Congress on Controversies to Consensus in Diabetes, Obesity & Hypertension

WORCESTER, Mass., Oct. 29, 2008 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (http://www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced today that, in addition to making three poster presentations of clinical data, it will host a satellite symposium at the 2nd World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (www.codhy.com) being held in Barcelona, Spain October 30 - November 2, 2008.
The... read more

Submitted by Avera

• 70 Views
• 0 Comments

Newly Identified Cells Make Fat

To understand where fat comes from, you have to start with a skinny mouse. By using such a creature, and observing the growth of fat after injections of different kinds of immature cells, scientists at the Howard Hughes Medical Institute and Rockefeller University have discovered an important fat precursor cell that may in time explain how changes in the numbers of fat cells might increase and lead to obesity. The finding, published online in this... read more

Submitted by Avera

• 64 Views
• 0 Comments

VIVUS Announces The Weight Loss Effects Of Qnexa In Type 2 Diabetes - Shows Weight Loss Of 17 Pounds In 28 Weeks

VIVUS, Inc. (NASDAQ: VVUS), a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products, today announced the weight loss effects of Qnexa in subjects with type 2 diabetes at The Obesity Society Annual Scientific Meeting in Phoenix, Arizona. Dr. Barbara Troupin, Senior Director of Clinical Development, announced the data in a poster presentation titled "The Weight Loss Effects of VI-0521 in Type 2 Diabetes." On an intent-to-treat basis, subjects treated with Qnexa,... read more

Submitted by Avera

• 77 Views
• 1 Comment